Cargando…
Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antibacterial effects in murine pneumococcal pneumonia
Autores principales: | Boogaard, F van den, Brands, X, Schultz, M, Levi, M, Roelofs, J, van't Veer, C, Poll, T van der |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776200/ http://dx.doi.org/10.1186/cc8083 |
Ejemplares similares
-
Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study
por: Schouten, Marcel, et al.
Publicado: (2012) -
Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study
por: Schouten, Marcel, et al.
Publicado: (2010) -
Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia
por: van den Boogaard, Florry E., et al.
Publicado: (2015) -
Overexpression of activated protein C hampers bacterial dissemination during pneumococcal pneumonia
por: de Boer, Johannes Daan, et al.
Publicado: (2014) -
DNA Methyltransferase 3b in Myeloid Cells Does Not Affect the Acute Immune Response in the Airways during Pseudomonas Pneumonia
por: Qin, Wanhai, et al.
Publicado: (2022)